Infliximab (Remicade®):: the magic bullet for Crohn's disease?

被引：7
作者：
D'Haens, G [1 ]
机构：
[1] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium
来源：
DIGESTIVE AND LIVER DISEASE | 2000年 / 32卷 / 08期
关键词：
D O I：
10.1016/S1590-8658(00)80324-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：653 / 656
页数：4
相关论文
共 21 条
[1]  
Beutler BA, 1999, J RHEUMATOL, V26, P16
[2]  
BRAEGGER C, 1999, GUT, V45, pA262
[3]   Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].
D'Haens, G ;
Van Deventer, S ;
Van Hogezand, R ;
Chalmers, D ;
Kothe, C ;
Baert, F ;
Braakman, T ;
Schaible, T ;
Geboes, K ;
Rutgeerts, P .
GASTROENTEROLOGY, 1999, 116 (05) :1029-1034
[4]  
D'Haens GR, 1999, GASTROENTEROLOGY, V116, pA696
[5]  
HAERT FJ, 1999, GASTROENTEROLOGY, V116, P22
[6]  
Hanauer SB, 1999, GASTROENTEROLOGY, V116, pA731
[7]   CONSTRUCTION AND INITIAL CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTI-TNF ANTIBODY [J].
KNIGHT, DM ;
TRINH, H ;
LE, JM ;
SIEGEL, S ;
SHEALY, D ;
MCDONOUGH, M ;
SCALLON, B ;
MOORE, MA ;
VILCEK, J ;
DADDONA, P ;
GHRAYEB, J .
MOLECULAR IMMUNOLOGY, 1993, 30 (16) :1443-1453
[8]  
Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO
[9]  
2-W
[10]  
McCabe RP, 1996, GASTROENTEROLOGY, V110, pA962
123